Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives

被引：1
|
作者：
Ottaiano, Alessandro [1 ]
Berretta, Massimiliano [2 ]
Von Arx, Claudia [1 ]
Capozzi, Monica [1 ]
Caraglia, Michele [3 ]
机构：
[1] Ist Ric & Cura Carattere Sci IRCCS G Pascale, Ist Nazl Tumori Napoli, Naples, Italy
[2] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[3] Univ Campania L Vanvitelli, Dept Precis Med, Naples, Italy
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
colorectal cancer; KRAS; BRAF; prognosis; therapy;
D O I：
10.3389/fonc.2022.852445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Challenges in patient selection for surgical options in V600E BRAF-mutated metastatic colorectal cancer.
    Maddalena, Giulia
    Perissinotto, Eleonora
    Intini, Rossana
    Morris II, Van K.
    Bergamo, Francesca
    Newhook, Timothy E.
    Lonardi, Sara
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 280 - 280
  • [32] FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial
    Damato, Angela
    Bergamo, Francesca
    Antonuzzo, Lorenzo
    Nasti, Guglielmo
    Iachetta, Francesco
    Romagnani, Alessandra
    Gervasi, Erika
    Larocca, Mario
    Pinto, Carmine
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Treatment options in BRAF-mutant metastatic colorectal cancer
    Bernabe-Ramirez, Carolina
    Patel, Rajvi
    Chahal, Jaspreet
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2020, 31 (06) : 545 - 557
  • [34] Current perspectives in the treatment of metastatic colorectal cancer
    Köhne, CH
    Folprecht, G
    ANNALS OF ONCOLOGY, 2004, 15 : 43 - 53
  • [35] Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC)
    Abid, Haisam
    Szabo, Aniko
    Taylor, Bradley W.
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Kamgar, Mandana
    Thomas, James P.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [36] Clonal Hematopoiesis Mutations in Plasma cfDNA RAS/BRAF Genotyping of Metastatic Colorectal Cancer
    Wang, B.
    Huang, F.
    Shen, M.
    Wu, S.
    Wang, H.
    Jiang, H.
    Yu, Y.
    Yu, Q.
    Yang, Y.
    Zhao, Y.
    Zhou, Y.
    Pan, B.
    Liu, T.
    Guo, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1187 - 1187
  • [37] Clonal hematopoiesis mutations in plasma cfDNA RAS/BRAF genotyping of metastatic colorectal cancer
    Wang, B.
    Huang, F.
    Shen, M.
    Wu, S.
    Wang, H.
    Jiang, H.
    Yu, Y.
    Yu, Q.
    Yang, Y.
    Zhao, Y.
    Zhou, Y.
    Pan, B.
    Liu, T.
    Guo, W.
    ANNALS OF ONCOLOGY, 2019, 30 : 237 - 237
  • [38] Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study
    Kayhanian, Hamzeh
    Goode, Emily
    Sclafani, Francesco
    Ang, Joo Ern
    Gerlinger, Marco
    de Castro, David Gonzalez
    Shepherd, Scott
    Peckitt, Clare
    Rao, Sheela
    Watkins, David
    Chau, Ian
    Cunningham, David
    Starling, Naureen
    CLINICAL COLORECTAL CANCER, 2018, 17 (01) : E69 - E76
  • [39] Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer:a retrospective observational study
    Xicheng Wang
    Qing Wei
    Jing Gao
    Jian Li
    Jie Li
    Jifang Gong
    Yanyan Li
    Lin Shen
    ChineseJournalofCancer, 2017, 36 (11) : 626 - 634
  • [40] Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
    Wang, Xicheng
    Wei, Qing
    Gao, Jing
    Li, Jian
    Li, Jie
    Gong, Jifang
    Li, Yanyan
    Shen, Lin
    CHINESE JOURNAL OF CANCER, 2017, 36
12345